News + Font Resize -

Sun Pharma gets US FDA approval for Docefrez injection
Our Bureau, Mumbai | Thursday, May 5, 2011, 12:20 Hrs  [IST]

Sun Pharmaceutical Industries Ltd. announced that US FDA has granted its subsidiary an approval for its New Drug Application (NDA) for Docefrez (docetaxel) for injection, 20 mg/vial and 80 mg/vial.

This NDA provides for the use of Docefrez (docetaxel) for injection, 20 mg/vial and 80 mg/vial for locally advanced or metastatic breast cancer, locally advanced or metastatic non-small cell lung cancer and hormone refractory metastatic prostate cancer.

Post Your Comment

 

Enquiry Form